To order call 800-533-4984 / 801-566-1200
In 2017, UTMD concluded a year in which all income statement measures were close to historical Company records. Consolidated sales were up a healthy 5.4%, $2.1 million higher in U.S. Dollar terms. But income before taxes jumped even more by $2.7 million, due to leverage in gross profit and operating income margins.
Despite a consecutive two year annual USD sales decline which we expect to reverse in 2017, UTMD was able to continue to achieve higher profits in 2016. Earnings Before Taxes (EBT) were up 6%, reflecting a consistent gross profit margin...
As expected, the big story with respect to the 2015 financial performance of Utah Medical Products, Inc. (NASDAQ: UTMD) was the relative strength of the U.S. Dollar. This was generally true of other companies in the medical device industry which have a significant portion of their sales outside the United States.
In 2014, Utah Medical Products, Inc. (UTMD) continued to achieve excellent overall financial operating performance and increase in shareholder value. The end of year share price was $60.05, up 5% from the end of 2013.
Utah Medical Products, Inc. (UTMD) followed an outstanding year in 2012 with an even better year in net income and earnings per share (EPS) in 2013. Importantly for stockholders, UTMD's share price rose 59%, to close the year of 2013 at $57.16.